MedPath

Bupropion in the treatment of adult ADHD

Phase 2
Completed
Conditions
Disturbance of activity and attention.
Disturbance of activity and attention
Registration Number
IRCT201302201556N51
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Inclusion Criteria: Diagnosis of ADHD based on DSM-IV ; age between 20-60

Exclusion Criteria

Chronic medical disease including seizure,cardiovascular disease, CVA and organic brain disease;substance abuse or dependence during past six months;nursing or pregnant patients; history of tic disorder; receiving of any psychotropics drugs during past two weeks, mental retardation ; history of suicide attempt, psychosis or aggressiveness; receiving psychotropic drugs; receiving psycho-stimulants or atomoxetine during past three months; bipolar disorder

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath